Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412"

Moshe Katz; Amit Meitus; Michael Arad; Anthony Aizer; Eyal Nof; Roy Beinart

doi:10.3390/jcm12185849

Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412"

J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.

Authors

Moshe Katz^{1

2

3}, Amit Meitus², Michael Arad^{1

2}, Anthony Aizer³, Eyal Nof^{1

2}, Roy Beinart^{1

2}

Affiliations

¹ Sheba Medical Center, Ramat Gan 5266202, Israel.
² School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
³ NYU Grossman School of Medicine, New York, NY 10016, USA.

Abstract

In a letter to the editor titled "How to improve clinical outcomes in patients with tachycardia-induced cardiomyopathy", Dr. Naoya Kataoka and Dr. Teruhiko Imamura [...].